Hematopoietic and Lymphoid Cell NeoplasmNCT06501040
Increasing Knowledge and Interest in Cancer Clinical Trials
A study testing Web-based Educational Intervention and Questionnaire Administration in people with Hematopoietic and Lymphoid Cell Neoplasm and Malignant Solid Neoplasm, run by Hayley Thompson at 1 site in United States.
Trial summary
This trial investigates how well a video-based clinical trial education session works in increasing knowledge and interest in cancer clinical trials among individuals in the metropolitan Detroit region of the Karmanos Cancer Institute (KCI) catchment area. Read more about this study
- Who is it for?
- Ages 21 years and olderHealthy volunteers can take part
- Conditions the study is for
- Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
- What is being tested?
- Web-based Educational Intervention and Questionnaire Administration
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 384 participants
- Where
- 1 siteUnited States
- Study dates
- 12 Jun 2020to 1 Feb 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 21 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Individuals aged 21 and older
- Participants will be identified through Karmanos Cancer Institute's (KCI) clinical treatment center
- Participants will be identified through community-based KCI-sponsored events
- Participants will have voiced an interest to participate followed by an Informed consent
Who cannot join
- none
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
Wayne State University/Karmanos Cancer Institute
Detroit, Michigan, 48201
Hayley Thompson, 313-576-9734, thompsoh@karmanos.org
Hayley Thompson
About this study
This trial investigates how well a video-based clinical trial education session works in increasing knowledge and interest in cancer clinical trials among individuals in the metropolitan Detroit region of the Karmanos Cancer Institute (KCI) catchment area. This educational activity may help researchers learn more about individuals' awareness of clinical trials, knowledge, and intention to participates in a clinical trial.
Read the detailed description
PRIMARY OBJECTIVE:
- To increase cancer clinical trial knowledge and interest through video-based education among individuals aged 21 and older in the metropolitan Detroit region of the KCI catchment area.
OUTLINE:
Participants view educational video consisting of information on the purpose of clinical trials, myths associated with clinical trials, and how to find more information about clinical trials.
- Being tested
- Web-based Educational Intervention, Questionnaire Administration
- Medical subject headings
- Hematologic Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Web-based Educational InterventionOther
Also called Education for Intervention
View web-based educational video
Questionnaire AdministrationOther
Pre video baseline survey and a post video educational survey
| Study group | Role | What they receive |
|---|---|---|
| Health Services Research (educational video) | Experimental | Participants view educational video consisting of information on the purpose of clinical trials, myths associated with clinical trials, and how to find more information about clinical trials. Receives: Other: Web-based Educational Intervention; Other: Questionnaire Administration |
What is being measured
The primary outcome is the main question the study is designed to answer.
Increase in Clinical Trial Awareness and Knowledge
An 11-question true and false questionnaire regarding Knowledge will be administered prior to and immediately after a video-based educational session on Clinical Trials
Measured: Baseline and immediately post intervention up to 1 day
Secondary outcomes (1)
Increase in intentions to participate in cancer clinical trials.
A 6-question standard Likert scale questionnaire regarding Intention will be administered prior to and immediately after a video-based educational session on Clinical Trials.
Measured: Baseline and immediately post intervention up to 1 day
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Jul 2024
- Study start12 Jun 2020
- Primary completion1 Feb 2028 (estimated)
- Study completion1 Feb 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Hematopoietic and Lymphoid Cell NeoplasmStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 384 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Hayley Thompson
- Sponsor type
- University, hospital or other
- Collaborators
- National Cancer Institute (NCI)
- Responsible party
- Sponsor-investigator, Hayley Thompson, Barbara Ann Karmanos Cancer Institute
- Investigators
- Hayley Thompson, Principal investigator, Barbara Ann Karmanos Cancer Institute
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06501040
- Sponsor's protocol ID
- 2019-137
- Other IDs
- NCI-2020-07119, 2019-137, P30CA022453
- Status last verified
- Jun 2026
- First submitted
- 3 May 2024
- Last updated
- 10 Jun 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 10 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Increasing Knowledge and Interest in Cancer Clinical Trials
- ClinicalTrials.gov ID
- NCT06501040
- Acronym / sponsor ID
- 2019-137
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 384 participants (estimated)
- Lead sponsor
- Hayley ThompsonUniversity, hospital or other
- Collaborators
- National Cancer Institute (NCI)
- Study start
- 12 Jun 2020 (actual)
- Primary completion
- 1 Feb 2028 (estimated)
- Study completion
- 1 Feb 2028 (estimated)
- First posted
- 15 Jul 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This trial investigates how well a video-based clinical trial education session works in increasing knowledge and interest in cancer clinical trials among individuals in the metropolitan Detroit region of the Karmanos Cancer Institute (KCI) catchment area. This educational activity may help researchers learn more about individuals' awareness of clinical trials, knowledge, and intention to participates in a clinical trial.
Detailed description
PRIMARY OBJECTIVE:
- To increase cancer clinical trial knowledge and interest through video-based education among individuals aged 21 and older in the metropolitan Detroit region of the KCI catchment area.
OUTLINE:
Participants view educational video consisting of information on the purpose of clinical trials, myths associated with clinical trials, and how to find more information about clinical trials.
Study design
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Health Services Research (educational video) | Experimental | Other: Web-based Educational Intervention, Other: Questionnaire AdministrationParticipants view educational video consisting of information on the purpose of clinical trials, myths associated with clinical trials, and how to find more information about clinical trials. |
Who may qualify
- Ages
- 21 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Individuals aged 21 and older
- Participants will be identified through Karmanos Cancer Institute's (KCI) clinical treatment center
- Participants will be identified through community-based KCI-sponsored events
- Participants will have voiced an interest to participate followed by an Informed consent
Key exclusion criteria (1 listed)
- none
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Web-based Educational InterventionAlso: Education for InterventionView web-based educational video | Other | Health Services Research (educational video) |
| Questionnaire AdministrationPre video baseline survey and a post video educational survey | Other | Health Services Research (educational video) |
Primary outcome
Increase in Clinical Trial Awareness and Knowledge
Time frame: Baseline and immediately post intervention up to 1 day
An 11-question true and false questionnaire regarding Knowledge will be administered prior to and immediately after a video-based educational session on Clinical Trials
1 secondary outcome
Increase in intentions to participate in cancer clinical trials.
Time frame: Baseline and immediately post intervention up to 1 day
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Jun 2026.
Related trials for Hematopoietic and Lymphoid Cell Neoplasm
Not yet recruitingPhase 4
MACE and BTK Inhibitors
Hematologic Cancer, MACE
Recruiting
An Exploratory Study to Evaluate Immune Determinants of the Response to Adoptive Cell Therapy (ACT) in Solid and Hematologic Tumors
Solid Tumor, Adult, Solid Tumor, Childhood
Active, not recruitingPhase 2
Testing AZD5363 as a Potential Targeted Treatment in Cancers With AKT Genetic Changes (MATCH-Subprotocol Y)
Advanced Lymphoma, Advanced Malignant Solid Neoplasm
Active, not recruitingPhase 1
Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers
Bladder Carcinoma, Cervical Carcinoma
Active, not recruitingPhase 2
Testing GDC-0032 (Taselisib) as a Potential Targeted Treatment in Cancers With PIK3CA Genetic Changes (MATCH-Subprotocol I)
Advanced Lymphoma, Advanced Malignant Solid Neoplasm
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Wayne State University/Karmanos Cancer Institute
Detroit, United States
Hayley Thompson principal investigator
Barbara Ann Karmanos Cancer Institute
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Web-based Educational Intervention and Questionnaire Administration in people with Hematopoietic and Lymphoid Cell Neoplasm and Malignant Solid Neoplasm, run by Hayley Thompson at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 10 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Increase in Clinical Trial Awareness and Knowledge (time frame: Baseline and immediately post intervention up to 1 day). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jun 2026.